In December 2016, the CDC announced it was considering whether to lower the reference level from to for consistency with the current 97.5th percentile of BLLs in U.S. children.25 The move is expected to increase the overall number of children whose BLLs are considered elevated. But Markowitz points out that the difference between 3.5 and 5 is within laboratory error for individual measurements, and that most commercial laboratories cannot measure lead accurately enough to the decimal place.The proposed measure is controversial for other reasons. Dietrich explicitly opposes the change, saying that public health officials and clinics have a hard-enough time as it is managing the population of children with a BLL in the range of . “My view is that proposal is statistically rather than health based and motivated to eliminate lead exposure entirely—not really an achievable goal,” he says.He also questions how this reduction would translate to public health practice. “I cannot say that a child with a BLL of is lead poisoned and predict neurodevelopmental impacts with any confidence. But that’s not how the new BLL will be interpreted by the media. And now you have these remarkable pronouncements coming out of Flint that kids with these low levels are permanently injured, which is complete nonsense,” he says. “The best we can do when we encounter such a low BLL is to alert parents of a potential exposure source in the child’s environment.”In Newman’s opinion, “what we really need to do is stop lead exposure, and insofar as lowering the reference level raises awareness and helps us accomplish that goal, I agree [it should be done].” He adds that lead screening means clinical interactions with children who, in many cases, are confronted by many neurodevelopmental risk factors: multigenerational poverty, nutritional problems, drug use, and more. “It provides an opportunity to help these kids and the rest of the family, too.”
Authors: W J Rogan; K N Dietrich; J H Ware; D W Dockery; M Salganik; J Radcliffe; R L Jones; N B Ragan; J J Chisolm; G G Rhoads Journal: N Engl J Med Date: 2001-05-10 Impact factor: 91.245
Authors: Weihong Yuan; Scott K Holland; Kim M Cecil; Kim N Dietrich; Stephanie D Wessel; Mekibib Altaye; Richard W Hornung; M Douglas Ris; John C Egelhoff; Bruce P Lanphear Journal: Pediatrics Date: 2006-09 Impact factor: 7.124